Delivery Order SPE2DE24DA017-SPE2D625F9EL7
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $9,900 on September 18, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 23, 2025, and represents work performed at Arthrex's Naples, Florida facility. The award was issued without a set-aside designation, reflecting the company's...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $3,300 on September 9, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment features an ultimate completion date of September 12, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain. The contract is not set aside for any...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $10,393.29 for the Arthrex ACP Double Syringe System on December 10, 2025, with an ultimate completion date of December 15, 2025. This fixed-price delivery order with economic price adjustment falls under a larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System on November 25, 2025, with a completion date of December 1, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F9EL7Delivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order on July 29, 2025, valued at $1,650.00 for the Arthrex ACP Double Syringe System. The contract, which is not set aside for any specific business type, represents a fixed-price delivery with economic price adjustment provisions and has an ultimate completion date of August 1, 2025. The award falls under the Defense Logistics Agency's Medical Supply Chain, a defense agency function supporting federal healthcare systems with specialized medical equipment. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and extending through September 2029. The ACP Double Syringe System is part of Arthrex's comprehensive portfolio of orthopedic surgical technologies, including implants, arthroscopic instruments, and biologics, which are distributed to Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. As a leading federal vendor in minimally invasive orthopedic solutions, Arthrex has consistently demonstrated its competitive capability in delivering advanced surgical systems to government healthcare systems with performance to occur in Naples, Florida.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/29/25 |